Related Experiment Video

Updated: Jun 18, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

Recent advances in antifungal prevention and treatment

Andreas H Groll1, Athanasios Tragiannidis

  • 1Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology, University Children's Hospital Muenster, Muenster, Germany. grollan@ukmuenster.de

Seminars in Hematology
|June 25, 2009
PubMed

Insights

Invasive fungal infections pose significant risks for immunocompromised patients. Advances in diagnosis and new antifungal treatments are improving management strategies for these serious infections.

Area of Science:

  • Medical Mycology
  • Hematology
  • Infectious Diseases

Background:

  • Invasive fungal infections (IFIs) are a major cause of death in patients with bone marrow failure, hematological cancers, or after allogeneic hematopoietic stem cell transplantation (HSCT).
  • Epidemiological trends show increasing infections from Aspergillus spp., non-albicans Candida spp., and rare fungi with reduced susceptibility to antifungals.
  • Recent decades brought significant progress in diagnosing IFIs and developing new antifungal drugs.

Purpose of the Study:

  • To review current strategies for preventing and treating opportunistic fungal infections in immunocompromised patients with hematological disorders.
  • To discuss emerging antifungal chemotherapy and adjunctive treatments for IFIs.

Main Methods:

  • Review of current literature on IFIs in immunocompromised patients.
  • Analysis of diagnostic advancements (clinical, laboratory, radiological).
  • Evaluation of new antifungal compounds and treatment paradigms.

Main Results:

  • Improved diagnostic capabilities for IFIs.
  • Development of novel antifungal agents and therapeutic approaches.
  • Established disease definitions and intervention strategies for IFIs.

Conclusions:

  • Management of IFIs in at-risk patients is evolving due to diagnostic and therapeutic advances.
  • Ongoing research is crucial for further improving outcomes in patients with hematological disorders and IFIs.

More Related Videos

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...